Realizing the Potential of CRISPR Gene Editing

Fyodor Urnov, director of technology and Translation at the Innovative Genomics Institute, about its efforts to advance genome editing technology, its work on sickle cell disease; and why it is critical for researchers to consider issues like access, affordability, and scalability in developing genetic medicines.